Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Doylestown, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aprea Therapeutics, Inc. has filed 425 SEC EDGAR filings since 12 Jul 2019

SEC filing history

Showing 176-200 of 425 matching filings.

Per page
25
Current page
8
SC 13G File 005-91159

SC 13G filing

Filing date
03 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Feb 2023
Reporting date
27 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-250041

424B5

Filing date
24 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-250041

424B5

Filing date
22 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-268816

FORM S-8

Filing date
15 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91159

SC 13D/A

Filing date
15 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39069

DEF 14A

Filing date
26 Oct 2022
Reporting date
16 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39069

PRE 14A

Filing date
11 Oct 2022
Reporting date
16 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-250041

424B5

Filing date
02 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .